SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Paul Bartosh who wrote (1817)3/18/1998 11:05:00 AM
From: Joe Wesley  Read Replies (1) | Respond to of 4676
 
Hi Paul:

Isis probably won't say anything about the conference. Look for an article about the conference in a magazine in a couple months.

Bloomberg TV ran a short headline on Isis last night a number of times that didn't note data problem was from Novartis (they owe Isis a correction).

Since this showed up after P1/2 testing and before an NDA and Novartis is paying for everything the news is a non-event.

Amateur



To: Paul Bartosh who wrote (1817)3/18/1998 11:05:00 PM
From: Perry  Read Replies (1) | Respond to of 4676
 
What conference are people refering to and does it involve their cancer drugs? Is ISIP presenting at this years annual American Association for Cancer Research (AACR) Conference? I have the abstract book for this conference but have yet to open it or even see when it is being held.

Thanks,
Perry

PS, any clue as to when the retinitis drug will be approved for marketing? What is a NDA or NDS (new drug submission)?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News